Recent developments indicate that Morocco is set to experience a substantial decline in the prices of nearly 300 medications, with reductions expected to range from 10% to 70%. This initiative marks the initial phase of a comprehensive reform aimed at revamping the pricing system for pharmaceuticals in the country. According to a source within the Ministry of Health and Social Protection, an initial list of approximately 300 medications has been approved, which will see varying price reductions available to the public in the near future.
This strategic move follows the issuance of Decree No. 2.25.631 on July 23, 2026, published in the official gazette on August 6, which introduced a series of modifications to the existing framework that had been in place since 2013. Notably, one of the key reforms includes a more frequent review of medication prices, transitioning from every five years to every three years. Additionally, new guidelines for price comparison with reference countries have been established, facilitating potential reductions in the prices of numerous medications.
The process does not conclude with this initial list, as the new framework mandates a reevaluation of the prices of medications already on the market within twelve months of its implementation. This suggests that further price adjustments are likely to occur in the forthcoming period. These measures are part of a broader objective to lower the costs of medications and improve access to healthcare, ultimately alleviating the financial burden on patients and reducing medication costs for the compulsory health insurance system.
As reported by hespress.com.
